SYS-CON MEDIA Authors: Gilad Parann-Nissany, RealWire News Distribution

News Feed Item

The Medicines Company to Announce Fourth Quarter and Full Year 2013 Financial Results on Wednesday, February 19, 2014

Conference Call to Be Held at 8:30 a.m. Eastern Time

PARSIPPANY, NJ -- (Marketwired) -- 02/06/14 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, February 19 at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2013 financial results, operational developments, and outlook for 2014.

The conference call will be available via phone and webcast. The dial-in information is listed below:

Domestic Dial In: + 1 866-318-8620
International Dial In: + 1 617-399-5139
Passcode for both dial-in numbers: 76913820

Replay is available from 12:30 p.m. Eastern Time following the conference call through February 26, 2014. To hear a replay of the call dial +1 888-286-8010 (domestic) and +1 617-801-6888 (international). Passcode for both dial in numbers is 98856638.

This call is being webcast and can be accessed via The Medicines Company website at www.themedicinescompany.com.

About The Medicines Company
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:

Neera Dahiya Ravindran, MD
The Medicines Company
+1 (973) 290-6044
neera.ravindran@themedco.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.